Wayne Frederick
Surgical Oncology · Washington, DCNPI 1962408252
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $831,743 of the $831,773 with a category attached, or 100.0%. Insulet Corporation accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $314,752 and has fallen 67.4% since, to $102,500 in 2025.
Across 24 payments — averaging $34,657 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$832K
- Integra Lifesciences Corporation$30
What the payments were for
- Speaking & faculty fees$831,743100%
- Food & beverage$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 23 | $831,743 |
| Integra Lifesciences Corporation | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$831,743
How this compares
Too few surgical oncology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Other surgical oncology in Washington
- Mihir ShahWashington$84K
- Danier MooreWashington$2K
- Bonnie SunWashington$2K
- Robin WilliamsWashington$1K
- Waddah Al-RefaieWashington$1K
- Victor GallWashington$598
- Quyen ChuWashington$442
- Joyce WongWashington$315
- Jeffrey PeltonWashington$276
- Mark StevesWashington$219
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.